HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCPC Weighs In On Hand Sanitizer ‘Kills 99.99% Of Germs’ Appeal Pending In Ninth Circuit

Executive Summary

Do reasonable consumers expect that a hand sanitizer advertised as lethal to 99.99% of germs will protect them against 99.99% of pathogens on the planet? Can a federal court address that point at the pleadings stage? Such questions will fall to the US Court of Appeals for the Ninth Circuit following dismissal of a putative class action against Vi-Jon in 2021 by California’s Southern District.

You may also be interested in...



Benzene Suits Against US Personal-Care Firms Appear Headed In One Direction: Settlement

The latest in litigation against Unilever, P&G, Beiersdorf and J&J alleging violations for selling personal-care products contaminated with benzene.

Beiersdorf Is Having Record Year For Sun Care, Seeing China Recovery, But Full-Year Outlook Is Guarded

The Hamburg, Germany-based firm defied economic and political headwinds and China troubles in the fiscal 2022 first half to book organic net sales growth of 10.5% to 4.5bn worldwide. Despite optimism about China recovery, sun care, and its recent Chantecaille acquisition, Beiersdorf is projecting a slowdown in the second half in what remains a volatile operating environment.

US FDA Seeks Benzene Testing Of 200 Drug Products By Contract Lab

The agency is calling for an ISO 17025-accredited or equivalent partner to screen selected drug products for benzene, following a rash of sunscreen, antiperspirant and other OTC drug product recalls which triggered a rush on testing laboratories, as well as class action filings across the US.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152747

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel